ADHD Med Increases Kids' CV Risk Later
the Psychiatry Advisor take:
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) that take methylphenidate-based medications to treat the condition have an elevated — though still very small — risk of developing heart problems later on.
Søren Dalsgaard, MD, of the National Center for Register-based Research at Aarhus University, Denmark, and colleagues examined data from 714,000 children born between 1990 and 1999 and found that the risk of developing cardiovascular (CV) problems was twice as high for those on a drug containing methylphenidate, which is sold under brand names including Concerta and Ritalin.
However, the risk of having a CV adverse event was just 1% in those treated with the drug, compared to approximately 0.5% in the group not on the medication, the researchers reported in the Journal of Child and Adolescent Psychopharmacology.
“I was surprised that the increased risk of heart problems was so high and that the risk did not only apply to children, who were already susceptible to heart ailments,” Dalsgaard said, according to ScienceNordic.com. “The result is worrying. It shows that clinicians must continue to be aware of the risk of heart ailments, when we prescribe medicine to ADHD patients.”
Results also showed that when a dose of methylphenidate was lowered during treatment, the risk of heart problems grew.
Common ADHD Drugs Slightly Increase CV Risk Later on For Children
The risk of developing heart problems was double for children taking methylphenidate for attention-deficit/hyperactivity disorder (ADHD) compared with children not prescribed the medicine.
The study builds on data from 714,000 children born in 1990-1999. It is the most comprehensive, data-based study within the field explains the head of the project Søren Dalsgaard, a psychiatrist at the National Center for Register-based Research at Aarhus University in Denmark.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Suicide Attempt Risk Among LGB Populations Higher Than Previously Estimated
- Residents Should Take Advantage of Paid Time Off
- Outpatient Engagement May Lower Suicide Attempts in Patients With Fibromyalgia
- Prevalence of Alzheimer Disease, Related Dementia Set to Double
- Forms of Childhood Adversity Related to First-Episode Psychosis Outcomes